Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs)

Michael B. Sporn, Nanjoo Suh, David J. Mangelsdorf

Research output: Contribution to journalReview articlepeer-review

143 Scopus citations


Peroxisome proliferator-activated receptor γ(PPARγ), a nuclear receptor and transcription factor that regulates the expression of many genes relevant to carcinogenesis, is now an important target for development of new drugs for the prevention and treatment of cancer. Deficient expression of PPARγ can be a significant risk factor for carcinogenesis, although in some cases overexpression enhances carcinogenesis. Ligands for PPARγ suppress breast carcinogenesis in experimental models and induce differentiation of human liposarcoma cells. By analogy to the selective estrogen receptor modulator (SERM) concept, it is suggested that selective PPARγ modulators (SPARMs), designed to have desired effects on specific genes and target tissues without undesirable effects on others, will be clinically important in the future for chemoprevention and chemotherapy of cancer.

Original languageEnglish (US)
Pages (from-to)395-400
Number of pages6
JournalTrends in Molecular Medicine
Issue number9
StatePublished - 2001

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology


Dive into the research topics of 'Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs)'. Together they form a unique fingerprint.

Cite this